Lv11
40 积分 2023-11-07 加入
Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination
5小时前
待确认
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias
2个月前
已完结
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias
2个月前
已关闭
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
3个月前
已完结
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel
4个月前
已完结
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
5个月前
已完结
Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation
5个月前
已完结
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications
5个月前
已完结
Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy?
5个月前
已完结
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications
5个月前
已完结
皖公网安备34019202002308
